Drugs Made In America Acquisition II Corp. Unit

Financial Services

NASDAQ:DMIIU · NASDAQ Global Select

Market Cap $703.79M Beta 0.06

$10.14 +0.20%

+$0.02 today

52W Low $9.94High $10.80

Vol 0.00M · Avg 0.00M

Asset Management

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+1.50%

Period High

$10.23

Period Low

$9.95

Latest

$10.14

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

General American Investors Company, Inc.

NYSE:GAM

$1.53B

Nuveen Churchill Direct Lending Corp.

NYSE:NCDL

$601.29M

Gladstone Investment Corporation

NASDAQ:GAIN

$588.39M

MSC Income Fund, Inc.

NYSE:MSIF

$534.85M

NewtekOne, Inc.

NASDAQ:NEWT

$393.09M

Eagle Point Income Company Inc.

NYSE:EIC

$236.33M

OFS Credit Company, Inc.

NASDAQ:OCCI

$74.02M

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.